U.S. Markets open in 7 hrs 30 mins

The Zacks Analyst Blog Highlights: Universal Health Services, VCA, Chemed and PAREXEL International

Zacks Equity Research

For Immediate Release

Chicago, IL – October 26, 2016 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Universal Health Services (NYSE:UHS –Free Report),VCA Inc. (NASDAQ:WOOF –Free Report),Chemed Corporation (NYSE:CHE –Free Report) and PAREXEL International Corporation (NASDAQ:PRXL – Free Report).

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Tuesday’s Analyst Blog:

Healthcare Earnings to Watch on October 26: UHS, WOOF, CHE, PRXL

We now have Q3 results from 116 S&P 500 members that combined account for 23.2% of the index’s total market capitalization as per the latest Earnings Preview report. Total earnings for these 116 companies are up 3.3% from the same period last year on 1.8% higher revenues, with 80.2% beating EPS estimates and 62.9% coming ahead of top-line expectations.

Healthcare comes under the Medical sector and is one of the seven sectors in the S&P 500 group. So far, 11.3% of the total Medical sector companies have reported third-quarter results. The sector is expected to deliver 3.7% earnings growth on 7.4% higher revenues this time around. This compares favorably with the projected 0.1% earnings growth on a 1.5% increase in revenues in the S&P 500 index.

Here, we take a sneak peek into four healthcare stocks scheduled to report their third-quarter figures on Oct 26:

Universal Health Services (NYSE:UHS – Free Report) through its subsidiaries, owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. Last quarter, Universal Health Services reported earnings of $1.94 per share, in line with the Zacks Consensus Estimate. It carries a Zacks Rank #3 (Hold). The company's Most Accurate Estimate stands at $1.59 per share, lower than the Zacks Consensus Estimate of $1.67 per share. So, theEarnings ESP for the company is-4.79%. Please check our Earnings ESP Filter that enables you to find stocks that are expected to come out with earnings surprises.

With respect to the surprise trend, though Universal Health Services surpassed expectations in only one of the last four quarters, it has managed to post an average beat of 0.53%.

The company’s acquisition of Desert View Regional Medical Center, a Nevada-based, twenty-five bed community care hospital of Rural Health Group (RHG), is a major catalyst in our view.

We believe the Desert View integration will fortify Universal Health’s footprint in Nevada where it already has Northern Nevada Medical Center and six acute-care operating wings in Las Vegas. As per management, this acquisition will not only strengthen Universal Health’s acute-care business in the existing markets but will also pave a way for the opening of a new 142-bed hospital in Henderson, in the fourth quarter of this fiscal.(Read more United Health: What's in Store this Earnings Season? )


VCA Inc. (NASDAQ:WOOF – Free Report) operates as an animal healthcare company in the United States and Canada. It operates through two segments – Animal Hospital and Laboratory. Last quarter, this company beat the estimate by 6.10%. VCA Inc. has an Earnings ESP of +1.24% and a Zacks Rank #2 (Buy). The Most Accurate Estimate stands at 82 cents per share a penny higher than the Zacks Consensus Estimate of 81 cents per share.

With respect to the surprise trend, VCA Inc. surpassed expectations in each of the last four quarters, with an average beat of 6.12%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here .

VCA INC Price and EPS Surprise | VCA INC Quote

Chemed Corporation (NYSE:CHE – Free Report) provides hospice and palliative care services in the United States. It operates through two segments, VITAS and Roto-Rooter. The company offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. Last quarter, this company missed the estimate by 0.58%. Chemed Corporation has an Earnings ESP of 0.00% as the Most Accurate Estimate stands at $1.80 per share, in line with the Zacks Consensus Estimate. The company carries a Zacks Rank #3. With respect to the surprise trend, Chemed Corporation surpassed expectations in two out of the last four quarters, with an average beat of 0.25%.

CHEMED CORP Price and EPS Surprise | CHEMED CORP Quote

PAREXEL International Corporation (NASDAQ:PRXL – Free Report), a biopharmaceutical services company, provides clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology products and services for the pharmaceutical, biotechnology, and medical device industries worldwide. Last quarter, this company beat the estimate by 2.17%. PAREXEL International has an Earnings ESP of 0.00% as the Most Accurate Estimate stands at 86 cents per share, in line with the Zacks Consensus Estimate. The company has a Zacks Rank #4 (Sell).

With respect to the surprise trend, PAREXEL International surpassed expectations in three out of the last four quarters, with an average beat of 9.58%.


Confidential from Zacks

This week, Zacks researchers have named 7 other stocks that look to break out even sooner than today's Bull of the Day. You can see these time-sensitive tickers free, and access additional trades that are not available to the public. Simply click here>>

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1 Stock of the Day pick for free.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year. See these high-potential stocks free >>.

Get the full Report on UHS - FREE

Get the full Report on WOOF - FREE

Get the full Report on CHE - FREE

Get the full Report on PRXL - FREE

Follow us on Twitter: https://twitter.com/zacksresearch

Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact
Zacks Investment Research

800-767-3771 ext. 9339



Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.

This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
UNIVL HLTH SVCS (UHS): Free Stock Analysis Report
VCA INC (WOOF): Free Stock Analysis Report
CHEMED CORP (CHE): Free Stock Analysis Report
PAREXEL INTL CP (PRXL): Free Stock Analysis Report
To read this article on Zacks.com click here.